Orchestra BioMed Holdings(OBIO)
$6.01+0.28 (+4.89%)
OBIO
Orchestra BioMed Holdings financials statements
$6.01
At close:+0.28 (+4.89%)
Want to see OBIO full AI Analyst Report?
Orchestra BioMed Holdings (OBIO) Ratios
120 Followers
Orchestra BioMed Holdings Ratios
OBIO's free cash flow for Q2 2026 was $-19.59M. For the 2026 fiscal year, OBIO's free cash flow was decreased by $-254.00K and operating cash flow was $-19.33M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.45 | 4.27 | 7.95 | 4.56 | 0.92 |
| Quick Ratio | 6.43 | 4.26 | 7.94 | 4.55 | 0.92 |
| Cash Ratio | 2.07 | 1.37 | 2.73 | 1.07 | 0.81 |
| Solvency Ratio | -1.02 | -1.40 | -1.80 | -0.78 | -0.27 |
| Operating Cash Flow Ratio | -2.93 | -3.12 | -4.12 | -1.58 | -1.59 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | -9.71 |
| Net Current Asset Value | $ 56.43M | $ 25.96M | $ 61.95M | $ 41.65M | $ -73.44M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.14 | 0.22 | 0.02 | 0.12 | 0.42 |
| Debt-to-Equity Ratio | 0.25 | 0.50 | 0.02 | 0.23 | -0.08 |
| Debt-to-Capital Ratio | 0.20 | 0.33 | 0.02 | 0.18 | -0.09 |
| Long-Term Debt-to-Capital Ratio | 0.18 | 0.30 | 0.00 | 0.15 | -0.05 |
| Financial Leverage Ratio | 1.81 | 2.31 | 1.40 | 1.82 | -0.19 |
| Debt Service Coverage Ratio | -44.62 | 0.00 | 0.00 | 0.00 | -7.39 |
| Interest Coverage Ratio | -45.13 | 0.00 | 0.00 | 0.00 | -23.52 |
| Debt to Market Cap | 0.07 | 0.10 | 0.00 | 0.04 | 0.03 |
| Interest Debt Per Share | 0.36 | 0.45 | 0.05 | 0.47 | 0.32 |
| Net Debt to EBITDA | 0.37 | 0.09 | 0.56 | 0.24 | 0.20 |
| Profitability Margins | |||||
| Gross Profit Margin | 99.43% | 92.27% | 93.26% | 90.89% | 125.45% |
| EBIT Margin | -153.97% | -2313.27% | -1866.16% | -924.34% | 2787.60% |
| EBITDA Margin | -153.00% | -2301.59% | -1855.76% | -918.06% | 2764.45% |
| Operating Profit Margin | -154.73% | -2437.49% | -1866.16% | -924.34% | 2787.60% |
| Pretax Profit Margin | -157.40% | -2313.27% | -1779.71% | -951.26% | 2942.97% |
| Net Profit Margin | -157.40% | -2313.27% | -1779.71% | -951.26% | 2942.97% |
| Continuous Operations Profit Margin | -157.40% | -2313.27% | -1779.71% | -951.26% | 2942.97% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 101.73% | 94.90% | 95.37% | 102.91% | 105.57% |
| Return on Assets (ROA) | -45.88% | -80.11% | -51.59% | -35.17% | -170.13% |
| Return on Equity (ROE) | -83.15% | -185.16% | -72.19% | -63.97% | 32.31% |
| Return on Capital Employed (ROCE) | -52.80% | -107.23% | -61.31% | -42.41% | -1693.78% |
| Return on Invested Capital (ROIC) | -52.40% | -106.25% | -60.84% | -42.03% | -663.19% |
| Return on Tangible Assets | -45.88% | -80.11% | -51.59% | -35.17% | -170.13% |
| Earnings Yield | -26.60% | -41.43% | -16.19% | -13.22% | -11.16% |
| Efficiency Ratios | |||||
| Receivables Turnover | 352.44 | 28.67 | 27.88 | 36.80 | -6.46 |
| Payables Turnover | 0.03 | 0.04 | 0.06 | 0.08 | 0.10 |
| Inventory Turnover | 0.61 | 1.18 | 1.27 | 1.17 | 2.93 |
| Fixed Asset Turnover | 10.43 | 0.76 | 0.97 | 0.96 | -0.70 |
| Asset Turnover | 0.29 | 0.03 | 0.03 | 0.04 | -0.06 |
| Working Capital Turnover Ratio | 0.46 | 0.04 | 0.04 | 0.11 | -0.07 |
| Cash Conversion Cycle | -11112.25 | -8863.57 | -5391.26 | -4175.11 | -3653.29 |
| Days of Sales Outstanding | 1.04 | 12.73 | 13.09 | 9.92 | -56.48 |
| Days of Inventory Outstanding | 595.53 | 309.53 | 286.51 | 312.86 | 124.72 |
| Days of Payables Outstanding | 11708.82 | 9185.83 | 5690.86 | 4497.89 | 3721.53 |
| Operating Cycle | 596.56 | 322.26 | 299.60 | 322.78 | 68.25 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.03 | -1.37 | -1.39 | -1.15 | -0.95 |
| Free Cash Flow Per Share | -1.04 | -1.38 | -1.39 | -1.17 | -0.96 |
| Dividend Paid and CapEx Coverage Ratio | -100.13 | -174.94 | -591.37 | -49.56 | -70.91 |
| Capital Expenditure Coverage Ratio | -100.13 | -174.94 | -591.37 | -49.56 | -70.91 |
| Operating Cash Flow Coverage Ratio | -3.07 | -3.06 | -27.34 | -2.47 | -3.42 |
| Operating Cash Flow to Sales Ratio | -1.46 | -19.17 | -16.71 | -8.29 | 24.85 |
| Free Cash Flow Yield | -24.96% | -34.52% | -15.23% | -11.75% | -9.56% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.74 | -2.41 | -6.18 | -7.56 | -8.96 |
| Price-to-Sales (P/S) Ratio | 5.92 | 55.83 | 109.91 | 71.95 | -263.60 |
| Price-to-Book (P/B) Ratio | 3.13 | 4.47 | 4.46 | 4.84 | -2.89 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.01 | -2.90 | -6.57 | -8.51 | -10.46 |
| Price-to-Operating Cash Flow Ratio | -4.05 | -2.91 | -6.58 | -8.68 | -10.61 |
| Price-to-Earnings Growth (PEG) Ratio | 0.11 | -0.20 | -0.51 | -0.00 | -0.08 |
| Enterprise Value Multiple | -3.50 | -2.33 | -5.36 | -7.59 | -9.34 |
| Enterprise Value | 179.42M | 141.55M | 274.47M | 246.30M | 201.87M |
| EV to EBITDA | -3.50 | -2.33 | -5.36 | -7.59 | -9.34 |
| EV to Sales | 5.36 | 53.66 | 99.45 | 69.71 | -258.15 |
| EV to Free Cash Flow | -3.63 | -2.78 | -5.94 | -8.24 | -10.25 |
| EV to Operating Cash Flow | -3.66 | -2.80 | -5.95 | -8.41 | -10.39 |
| Tangible Book Value Per Share | 1.33 | 0.90 | 2.05 | 2.06 | -3.48 |
| Shareholders’ Equity Per Share | 1.33 | 0.90 | 2.05 | 2.06 | -3.48 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.70 | 0.07 | 0.08 | 0.14 | -0.04 |
| Net Income Per Share | -1.10 | -1.66 | -1.48 | -1.32 | -1.13 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.02 | 1.00 | 0.95 | 1.03 | 1.06 |
| Research & Development to Revenue | 1.74 | 16.23 | 12.25 | 6.21 | -16.48 |
| SG&A to Revenue | 0.80 | 9.07 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.36 | 4.02 | 2.76 | 0.97 | -0.39 |
| Income Quality | 0.93 | 0.83 | 0.94 | 0.87 | 0.84 |
Currency in USD
